ID: ALA2397325

Max Phase: Preclinical

Molecular Formula: C13H26O5

Molecular Weight: 262.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COCCOCCOCCCCCCCC(=O)O

Standard InChI:  InChI=1S/C13H26O5/c1-16-9-10-18-12-11-17-8-6-4-2-3-5-7-13(14)15/h2-12H2,1H3,(H,14,15)

Standard InChI Key:  AGSKIYCUDCEVNJ-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 262.35Molecular Weight (Monoisotopic): 262.1780AlogP: 2.09#Rotatable Bonds: 14
Polar Surface Area: 64.99Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.63CX Basic pKa: CX LogP: 1.81CX LogD: -0.89
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.49Np Likeness Score: -0.05

References

1. Marshall AJ, Lin JM, Grey A, Reid IR, Cornish J, Denny WA..  (2013)  Long-chain triazolyl acids as inhibitors of osteoclastogenesis.,  21  (14): [PMID:23726411] [10.1016/j.bmc.2013.05.013]

Source